NFKBIA and diabetes mellitus: Knocking down TRAF6 showed to inhibit the degradation of IκB-α and JNK phosphorylation that are induced by a high glucose level; thus, targeting TRAF6 could be of value to delay the progression of vascular diseases associated with diabetes (R. Liu et al., 2018).